Analyzing the molecular character of the CTCs we may conclude that in our GC CTCs samples, an increased cytokeratin-18 and cytokeratin-19 expression was seen in all of the tested samples, with some redundant EpCAM and MUC1 expression as well. The gene discussed is KRT18; the disease is gastric cancer.